Copper is essential for life, and beyond its well-established ability to serve as a tightly-bound, redox-active active site cofactor for enzyme function, emerging data suggest that cellular copper also exists in labile pools, defined as loosely bound to low molecular weight ligands, which can regulate diverse transition metal signaling processes spanning neural communication and olfaction, lipolysis, rest-activity cycles, and kinase pathways critical for oncogenic signaling. To help decipher this growing biology, we report a first-generation ratiometric fluorescence resonance energy transfer (FRET) copper probe, FCP-1, for activity-based sensing of labile Cu(I) pools in live cells. FCP-1 links fluorescein and rhodamine dyes through a tris[(2pyridyl)methyl]amine (TPA) bridge. Bioinspired Cu(I)-induced oxidative cleavage decreases FRET between fluorescein donor and rhodamine acceptor. FCP-1 responds to Cu(I) with high metal selectivity and oxidation-state specificity and facilitates ratiometric measurements that minimize potential interferences arising from variations in sample thickness, dye concentration, and light intensity. FCP-1 enables imaging of dynamic changes in labile Cu(I) pools in live cells in response to copper supplementation/depletion, differential expression of the copper importer CTR1, and redox stress induced by manipulating intracellular glutathione levels and GSH/GSSG ratios. FCP-1 imaging reveals a labile Cu(I) deficiency induced by oncogene-driven cellular transformation that promotes fluctuations in glutathione metabolism, where lower GSH/GSSG ratios decrease labile Cu(I) availability without affecting total copper levels. By connecting copper dysregulation and glutathione stress in cancer, this work provides a valuable starting point to study broader crosstalk between metal and redox pathways in health and disease with activity-based probes.
Introduction
Copper is a required redox-active nutrient for life (1), serving as a potent catalytic and/or structural cofactor in proteins for fundamental processes such as oxygen transport, respiration and metabolism, cell growth and differentiation, and signal transduction (2) (3) (4) (5) (6) . In addition to tightly-bound copper pools buried within metalloprotein active sites, emerging data suggest the presence of labile copper pools that are bound relatively weakly by low molecular weight ligands (7) . Labile copper pools contribute to a growing number of dynamic transition metal signaling pathways (8) including neural communication (9) (10) (11) , olfaction (12, 13) , lipolysis (6) , restactivity cycles (14) , and kinase pathways involved in signal transduction and oncogenesis (5, 15) . Indeed, copper dysregulation can result in aberrant oxidative and nitrosative stress events that accompany diseases spanning cancer (5, 16) , cardiovascular disorders, neurodegenerative Alzheimer's, Parkinson's and Huntington's diseases (3, 17) , diabetes and obesity, and genetic Menkes and Wilson disorders (18) (19) (20) (21) .
The signal/stress dichotomy of copper motivates the development of new chemical tools to help decipher its broader contributions to physiology and pathology.
In this context, fluorescent (6, 10, 11, 14, (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) , bioluminescent (39) , and magnetic resonance imaging probes (40) (41) (42) for visualizing labile copper pools with metal and oxidation state specificity, particularly when used in concert with complementary techniques for measuring total metal content (22, 43, 44) , including laser ablation inductively-coupled plasma mass spectrometry (LA-ICP-MS) (45) (46) (47) , nanoscale secondary ion mass spectrometry (nano-SIMS) (38, 48) , and X-ray fluorescence microscopy (XFM) (10, 49, 50) , can provide a coherent picture of metal homeostasis for a given biological model. Along these lines, a chemical limitation in fluorescent probe development is that the vast majority of copper indicators to date only respond through changes in fluorescence intensity in a single color, which can complicate quantitative measurements of copper pools and/or comparison of copper levels across different biological specimens owing to potential variations in probe uptake along with interferences arising from copper-independent phenomena, such as heterogeneities in sample thickness and light intensity (51, 52) . To address this issue, ratiometric probes, which utilize excitation/emission spectral changes over two or more wavelengths, can in principle enable internal self-calibration for nonhomogenous probe loading and limit interferences across variable specimens (53) (54) (55) (56) (57) .
However, the few ratiometric fluorescent copper indicators reported to date are limited largely by a lack of oxidation state specificity and/or decrease in overall fluorescence intensity upon copper detection (31) (32) (33) (34) (35) (36) (37) . P.4 We now present the design, synthesis, and biological applications of a firstgeneration ratiometric fluorescent copper indicator, FRET Copper Probe 1 (FCP-1).
This activity-based sensing probe exploits the chemoselective Cu(I)-dependent oxidative CO cleavage of a tris[(2-pyridyl)methyl]amine (TPA) (28, 58, 59) unit linking fluorescein donor and rhodamine acceptor units (Scheme 1). The high metal and oxidation state specificity of FCP-1 for Cu(I), along with its two-color ratiometric FRET response, enables its use to monitor dynamic changes in labile Cu(I) pools in live cells. Owing to the self-calibration afforded by its ratiometric response, FCP-1 was capable of reliably detecting decreases in endogenous levels of labile Cu(I) in mouse embryonic fibroblasts (MEFs) lacking the high-affinity copper transporter Ctr1 (Ctr1 -/-) relative to wildtype congeners. Further experiments identified fluctuations in labile Cu(I) levels, but not total copper levels, under redox stress induced by genetic alterations to glutathione biosynthesis pathways. Interestingly, a deficiency in labile Cu(I) pools was found by introduction of oncogenic BRAF V600E or KRAS G12D , linking labile copper dysregulation to oncogene-dependent redox status. The ability of FCP-1 to monitor labile Cu(I) pools with a ratiometric response provides a starting point for further studies of redox contributions to transition metal signaling.
Results and Discussion
Design, Synthesis and Characterization of FCP-1. Inspired by bioinorganic TPA model compounds that exhibit Cu(I)-dependent oxidative cleavage chemistry (28, 58, 59) , our design of FCP-1 in Scheme 1 connects a fluorescein FRET donor and rhodamine FRET acceptor with copper-responsive TPA linker. Changes in labile Cu(I) levels would modulate intramolecular FRET efficiency and lead to different fluorescence intensities of the donor and acceptor at two different wavelengths that can be self-calibrated in a ratiometric manner. Under lower Cu(I) levels, the probe stays intact with higher FRET and rhodamine-dominant emission, with higher Cu(I) levels leading to copper-dependent oxidative cleavage of the TPA linker and lower FRET and fluorescein-dominant emission.
The synthesis of FCP-1 starts with preparation of the 2-bromomethylpyridinefunctionalized fluorescein methyl ester (2) and picolylamine-functionalized rhodamine (5; Scheme 2). Compound 2 was synthesized in 2 steps from the previously reported fluorescein methyl ester by nucleophilic substitution onto 6-(bromomethyl)-2-pyridinemethanol and subsequent bromination of the methyl alcohol.
In parallel, nosyl-protected picolylamine (3) was prepared by monosubstitution of bis(chloromethyl)pyridine from 4-nitro-N-(2-pyridinylmethyl)benzenesulfonamide and then reacted with piperazinyl-functionalized rhodamine (Pz-rhodamine) to afford 4. Subsequently nosyl group of 4 is deprotected by thiophenol and K2CO3 to yield 5.
P.5
With the key pieces 2 and 5 in hand, TPA motif can be generated through nucleophilic substitution of 2-bromomethyl group on 2 by the picolylamine on 5 under basic conditions, furnishing the final ratiometric probe FCP-1 that was characterized by 1 H and 13 C{ 1 H} NMR, high-resolution mass spectrometry (HRMS), and liquid chromatography-coupled mass spectrometry (LC−MS; Fig. S1 ). The intensity-based Cu(I) probe FL-TPA was prepared as a control compound with the same Cu(I)-dependent activity-based sensing trigger and fluorescein scaffold but lacking a ratiometric response (Scheme 2).
Reactivity and Selectivity of FCP-1 to Copper.
The intracellular environment is known to be reducing and contains high concentrations of biomolecules that results in macromolecular crowding (60, 61) . As such, to mimic aspects of these properties in vitro, we evaluated FCP-1 in PBS buffer containing glutathione (2 mM) and PEG-400 (40%, v/v). FCP-1 showed absorption maxima at 465, 493 and 552 nm, with molar extinction coefficients of 20,000, 22,100 and 40,000 M 1 cm 1 , respectively (Fig. S2 ).
The first two absorption maxima corresponded to the absorption of the fluorescein moiety, as similar absorption maxima at 460 and 489 nm were found in the absorption spectra of FL-TPA ( Fig. S2 ) and reported monocaged fluorescein methyl ester (62, 63) , whereas the lowest energy absorption at 552 nm originated from the rhodamine moiety ( Fig. S2 ). Upon photoexcitation at 458 nm, FCP-1 was found to emit at 526 and 576 nm ( Fig. 1A ), corresponding to fluorescein and rhodamine signatures, respectively. Notably, the Pz-rhodamine building block shows only weak absorption at 458 nm ( Fig. S2 ). Together with the significant contribution of the lower-energy fluorescence from the excitation at 450500 nm, which is in the region of FL-TPA absorption ( Fig. S3 ), the data support the occurence of FRET from the fluorescein donor to the rhodamine acceptor. Using FL-TPA as a reference FRET donor compound ( Fig. S4 ) with assumption that quenching of donor fluorescence originated only from the FRET process, the FRET efficiency in the FCP-1 cassette is estimated to be 84%. The ratiometric fluorescence change of FCP-1 at 526 and 576 nm (F526 / F576) was rapid and reached saturation after ca. 30 min in the presence of a two-fold excess of Cu(I) (10 μM). Notably, the F526 / F576 ratio of FCP-1 showed a linear dose response with Cu(I) addition from 0.01 to 1 µM ( Fig. S7A ), highlighting the capability of FCP-1 to detect Cu(I) levels in this range by a ratiometric fluorescence change. FCP-1 showed high sensitivity to Cu(I), as revealed by the detectable emission spectral changes at 10 nM of Cu(I) ( Fig. S7B ) and a detection limit of 16.7 nM based on the 3 method from 5 independent experiments (64, 65) . More interestingly, the basal F526 / F576 FCP-1 emission ratio did not show significant changes with varying concentrations of probe (0.5 to 20 µM, Figs. 1B and 1C). This internal self-calibration is advantageous, as FCP-1 was found to be less fluorescent at higher concentrations, presumably due to self-quenching, which is a common issue found in fluorophores ( Fig. S8 ) (66) . Indeed, the negligible changes in ratiometric emission of FCP-1 indicated that FRET occurred primarily through an intramolecular mechanism, and concentration-independent ratiometric fluorescence of FCP-1 further highlights its potential in comparative imaging of labile Cu(I) pools in biological specimens by avoiding potential complications arising from variations in probe uptake, sample thickness, and light intensity.
The ratiometric fluorescence change of FCP-1 was selective toward Cu(I) over other biologically relevant metal ions, except free Co(II) at 10 μM, which altered FCP-1 fluorescence modestly ( Fig. 1D ). Notably, this concentration of exogenous Co(II) is far higher than the physiologically relevant levels of labile Co(II), as this metal ion is known to be tightly bound by proteins. Indeed, FCP-1 showed no significant changes in ratiometric signal in the presence of 10 μM cobalamin (vitamin B12) (67) , which is the predominant form of Co(II) in mammalian systems, suggesting that interference in the detection of Cu(I) by FCP-1 from Co(II) in biological specimens should be negligible. Competitive experiments further showed the ability of FCP-1 to detect Cu(I) in solutions containing other biologically relevant metal ions ( Fig. 1D ). In addition to exhibiting metal selectivity, the ratiometric response of FCP-1 is oxidation state-specific for Cu(I), as the probe does not respond ratiometrically to Cu(II) (Figs. 1E and 1F). In further support of this oxidation state selectivity, coincubation of FCP-1 with Cu(II) and excess glutathione, which readily reduces Cu(II) to Cu(I), resulted in emission spectra and a F526 / F576 ratio that is identical to that 
FCP-1 Can Image Labile Cu(I) Pools in Living Cells.
Given the metal and oxidation state-selective and sensitive response of FCP-1 to Cu(I), we sought to apply this probe for ratiometric fluorescence imaging of labile Cu(I) pools in living cells. To this end, HEK 293T cells were exposed to varying doses of CuCl2 (25-300 µM), washed thoroughly to remove excess copper from the medium, and then incubated with FCP-1 (5 μM) for 45 min and imaged. The copper-supplemented cells showed a statistically significant, dose-dependent increase in Fgreen / Forange ratio over vehicle control cells (Fig. 2B ). In contrast, copper-deficient HEK 293T cells obtained by treatment with a membrane-impermeable copper chelator, bathocuproine sulfonate (BCS; 100 μM), washed, and subsequently incubated with FCP-1 (5 μM) exhibited a statistically significant decrease in Fgreen / Forange ratio when compared to control cells total copper pool ( Fig. 2E) . Control experiments showed that the cells remained viable as indicated by nuclear staining (Figs. S12 and S13). These data establish that FCP-1 is capable of visualizing both increases and decreases in labile Cu(I) pools in living cells by a ratiometric fluorescence readout. (Figs. S14 and S15). The difference of FCP-1 ratiometric fluorescence response to exogenous copper supplementation between the wildtype and Ctr1 knockout MEFs is consistent with inefficient copper uptake rather than changes in copper efflux, as treatment of Ctr1 -/-MEFs with the membrane-impermeable copper chelator BCS resulted in a reduction in Fgreen / Forange ratio, similar to what is observed in Ctr1 +/+ MEFs (Figs. 3A and 3B). Complementary ICP-MS measurements confirm that total copper levels in Ctr1 -/-MEFs are lower than Ctr1 +/+ MEFs (Fig. S16) . Importantly, the ratiometric response of FCP-1 is key to its ability to distinguish between basal and decreased levels of labile Cu(I). Indeed, the control probe FL-TPA, which exhibits a "turn-on" fluorescence response without ratiometric self-calibration, was unable to distinguish differences in basal labile Cu(I) levels in Ctr1 +/+ MEFs and Ctr1 -/-MEFs (Figs. 3C and 3D), while being able to detect changes in labile copper with exogenous copper addition (Fig. S17 ). This result can be explained by potential differences in probe loading into the two MEF cell lines, further highlighting the self-calibrating nature of the ratiometric probe FCP-1 as a critical feature for accurate detection of P.9 analyte levels across different, variable biological specimens. Finally, we tested whether FCP-1 could disrupt labile Cu pools by measuring CCS protein levels in MEFs treated with FCP-1 or BCS, the latter as a positive control to reduce cellular Cu content and promote CCS protein stability. Indeed, CCS protein levels were unaltered in cells treated with a concentration of FCP-1 sufficient to visualize cellular labile Cu pools, while BCS treatment increased CCS, as expected ( Fig. S18 ), confirming that FCP-1, itself, does not alter cellular Cu levels under these conditions. The data demonstrate that FCP-1 can monitor basal levels of endogenous labile Cu(I) and depletion of such pools in response to reduced cellular copper uptake through either genetic or pharmacologic means. With these results in hand, we next sought to utilize FCP-1 to explore potential connections between the maintenance of labile Cu(I) pools and endogenous central redox mediators in the cell. In this context, glutathione (GSH) is a ubiquitous, naturally-occurring antioxidant and a key small molecule for maintaining proper cellular redox status (71) . The rate-determining step of GSH biosynthesis involves glutamate cysteine ligase (GCL), which can be inhibited by buthionine sulfoximine (BSO) (72) . Interestingly, we observed that the FCP-1 Fgreen / Forange ratio was higher in BSO-treated HeLa cells when compared to control cells (Fig. 4B ), indicating an increase in labile Cu(I) levels when GSH synthesis is blocked. Moreover, total intracellular copper levels did not differ significantly between the BSO-pretreated cells and control cells as shown by ICP-MS (Fig. 4C) , showing that the dynamic P.10 changes are in the labile Cu(I) pool rather than an overall increase or decrease in the total copper pool. On balance, we caution against overinterpreting these data as supporting a simple and direct Cu(I)-glutathione complexation model, as although aqueous solutions of FCP-1 and Cu(I) were found to show higher F526 / F576 ratios at lower GSH concentrations in vitro (Fig. S19) , the variable Kd values and copperligand stoichiometries obtained under different buffer conditions do not rule out more sophisticated interplay between metal and redox homeostasis pathways (7, 22, 73) .
FCP-1 Can Monitor Differences in Labile Cu(I) Levels in a Genetic

FCP-1 Identifies a Dynamic Change in Labile Cu(I) Versus Total Copper
Indeed, GSH is not just a reducing agents but also has been reported to interact with metallochaperones like ATOX1 or metal-buffering/scavenging proteins such as metallothionein to form complexes that can bind copper tightly (73) (74) (75) (76) . Therefore, the observed increase in labile Cu(I) levels resulting from GSH deficiency may be operating through more complex, indirect mechanisms, an area that warrants further study.
To further investigate correlations between labile Cu(I) pools and altered GSH metabolism, we prepared two MEF cell lines for study, where one line exhibits lower levels of total GSH via stable genetic knockdown of endogenous Gclc (the catalytic subunit of the rate limiting enzyme GCL in GSH synthesis) and the other line exhibits lower levels of GSH and a lower ratio of reduced to oxidized GSH (GSH/GSSG) via knockdown of glutathione reductase (Gsr; the NADPH dependent-enzyme that cleaves the disulfide bond on two oxidized GSH molecules) (71, 77) . As expected, shRNA-mediated knockdown of endogenous Gclc (Figs. 5A and B ) significantly reduced total GSH levels to a similar degree to MEFs treated with BSO, which potently inhibits GCLC enzymatic function, when compared to non-targeting scramble control (Scr) MEFs (Fig. 5C ). Importantly, no significant change in the GSH/GSSG ratio is observed in these Gclc knockdown cells despite the lower total GSH levels ( Fig. 5D ). In contrast, genetic knockdown of Gsr via shRNA significantly lowered both total GSH levels and the GSH/GSSG ratio, while treatment with the 5G and 5H). Since Gclc knockdown inhibits the enzyme involved in the ratedetermining step of GSH biosynthesis and mimics pharmacological treatment with P.11 BSO (Fig. 4B) , we attribute the observed increase in Fgreen / Forange ratio to the decrease in total GSH levels. The minimal change in GSH/GSSG ratio in this Gclc knockdown cell line suggests that the overall cellular redox state is unaffected and instead points to decreases in levels of labile Cu(I)-buffering systems (Fig. 5I ).
Included are potential GSH-metallochaperone or GSH-metallothionein adducts, both of which can influence loosely-bound vs tightly-bound Cu(I) pools. On the other hand, Gsr knockdown cells showed a lower GSH/GSSG ratio (Fig. 5D ), which reflects a more overall oxidizing intracellular environment and may lead to a shift in the dynamic balance of Cu(I/II) pools, which results in a decrease in labile Cu(I) levels ( Fig. 5I ). Although total GSH levels also decrease in Gsr knockdown cells, which may increase bioavailability of labile Cu(I) to some extent, the statistically significant decrease in the FCP-1 Fgreen / Forange ratio relative to control indicates an overall labile Cu(I) deficiency and suggests that the redox contribution of more GSSG relative to GSH is the dominant contributor. Because the FCP-1 activity-based sensing mechanism relies on an oxygen-dependent redox reaction with Cu(I), we performed an additional set of control experiments using a previously reported copper fluorescent turn-on probe, Copper Fluor-4 (CF4), that operates by a direct, reversible Cu(I) binding-based mechanism (14) . CF4 showed increased fluorescence in Gclc knockout cell lines but decreased fluorescence in Gsr knockout cells, which agrees well with those obtained with FCP-1 ( Fig. S20) , providing further support for changes in labile Cu(I) pools induced by alterations in GSH and GSH/GSSG status. Finally, whereas the labile Cu(I) pools change in MEFs lacking Gclc or Gsr, no changes in total copper content were observed as measured by ICP-MS (Fig. 5J) . These experiments reveal that labile Cu(I) pools can be elevated and/or depleted in a glutathione-dependent manner depending on both total GSH levels as well as GSH/GSSG redox ratios.
Oncogenic BRAF V600E and KRAS G12 Mutations Lead to Labile Cu(I) Deficiency
Due in Part to Decreased Expression of GSR and Diminished Ability to
Regenerate GSH. Noting the growing connections between copper and kinase signaling pathways involved in oncogenesis, we next sought to apply the identification of copper-glutathione crosstalk to tumorigenesis. Indeed, rapid proliferation associated with tumorigenesis requires cancer cells to increase energy metabolism and initiate cellular mechanisms to respond to oncogenic stress to sustain unrestricted tumor growth, survival, and therapeutic resistance. For example, many solid tumors display increased reactive oxygen species (ROS) production in response to higher energic needs and mitochondrial dysfunction. As a result, this induces an antioxidant program to detoxify from ROS and maintain a more robust redox balance P.12 (78) . For example, MEFs expressing conditional oncogenic alleles of KRAS G12D or BRAF V619E display reduced levels of intracellular ROS with concomitant increases in mRNA expression of the glutathione metabolism genes Gclc and Gclm (79) .
Moreover, ectopic expression of KRAS G12D increased total GSH levels yet a lower GSH/GSSG ratio. However, whether oncogenic mutations in BRAF or KRAS alter the intracellular pools of labile Cu(I) by disrupting intracellular redox balance, particularly through glutathione pathways, remains insufficiently understood.
To address this question, immortalized MEFs were transformed with BRAF V600E or KRAS G12D and levels of intracellular labile Cu(I) were assessed with ratiometric FCP-1 imaging. Interestingly, we observed a decrease in the average cellular ratiometric fluorescence from both BRAF V600E and KRAS G12D -transformed ). In agreement, we found that CCS protein stability, which is degraded in a Cudependent fashion, is increased in cells stably expressing these oncogenes or when cells are treated with the Cu chelator BCS, as a positive control, suggesting a depletion of labile intracellular Cu pools (Fig. 6C ). To determine whether the observed labile Cu(I) deficiency as detected by live-cell FCP-1 and CF4 imaging was reflected in changes in total cellular Cu levels, ICP-MS was performed on control, BRAF V600E , or KRAS G12D expressing MEFs, and these cells showed unchanged total Cu levels ( Fig. 6D) , confirming that labile Cu(I) pool is selectively altered rather than the total Cu pool. Furthermore, Ctr1 transcript levels in both BRAF V600E and KRAS G12D cells remain similar to control cells, suggesting that the observed decrease in labile Cu(I) levels is not due to changes in cellular Cu import (Fig. 6E ). Although Atp7a transcript levels were insignificantly lower in both BRAF V600E and KRAS G12D cells (Fig. 6F ), these changes in Atp7a mRNA expression may reflect the cells sensing lower bioavailable Cu(I) levels. As an alternative hypothesis to differential expression of the Cu transporters CTR1 and ATP7A to decrease labile Cu(I) levels, recent studies have established that decreasing the levels of CTR1 or introducing surface accessible mutations in MEK1, which functions downstream of oncogenic BRAF V600E , as an approach to disrupt Cu binding decreased BRAF V600E -driven signaling and tumor growth (5, 80) . Thus, the Cu-MEK1/2 interaction is essential for BRAF V600E -driven signaling and tumorigenesis and decreased labile Cu levels in BRAF V600E -transformed MEFs could potentially be driven by increased delivery of Cu to MEK1/2 to support hyperactivated MAPK signaling. To experimentally address this possibility, BRAF V600E -transformed MEFs were engineered to stably express scramble shRNA or P.13
Mek1 shRNA with RNA-mediated interference-resistant wild-type MEK1 or a Cubinding mutant of MEK1 (MEK1 CBM ) and the ratiometric fluorescence from FCP-1 in these cell lines was compared to non-transformed MEFs. While BRAF V600E expression reduced Fgreen / Forange by ~20%, the decrease was maintained in the presence of both wild-type MEK1 and MEK1 CBM , suggesting that the observed decrease in the labile Cu(I) pool is independent of MEK1/2 Cu binding (Fig. S22) .
Given our collective results that indicate that Cu(I) appears less bioavailable in the context of oncogenic transformation, we hypothesized that differences in glutathione metabolism may be driving the phenotype. To this end, we tested total GSH levels and the GSH/GSSG ratios in MEFs transformed with oncogenic BRAF V600E or KRAS G12D and found that expression of either oncogene increased total GSH levels, although only statistically significant in the KRAS G12D cells (Fig. 6G) . To our surprise, GSH/GSSG ratios were significantly lower in the BRAF V600E and KRAS G12D stably expressing MEFs when compared to control cells (Fig. 6H ). Since the BRAF V600E -and KRAS G12D -transformed MEFs phenocopied the genetic knockdown of Gsr with respect to reduced ratiometric fluorescence from FCP-1 and a diminished GSH/GSSG ratio, Gsr mRNA levels and protein expression were interrogated. When normalized to control cells, Gsr transcript levels were significantly reduced upon stable expression of either BRAF V600E or KRAS G12D , whereas Gclc transcript levels remained relatively unchanged amongst them (Figs. 6I and 6J). Parallel with Gsr transcript levels, GSR protein expression was reduced in the BRAF V600E and KRAS G12D cells when compared to control cells (Fig. 6K) . In contrast, GCLC protein levels were higher in the BRAF V600E and KRAS G12D cells when compared to control cells (Fig. 6K) . To further support the connection between oncogenesis, copper homeostasis, and alterations in glutathione metabolism enzyme expression, both BRAF V600E and KRAS G12D significantly increased the levels of CellROX green fluorescence ( Fig. 6L ), suggesting that oncogenic transformation increases ROS and in turn reduces the labile Cu(I) pool. From these data, we conclude that BRAF V600E and KRAS G12D -transformed cells exhibit a labile Cu(I) deficiency in part due to decreased levels of Gsr and increased levels of ROS, which both may foster a more oxidized cellular environment due to the inability to regenerate GSH ( Fig. 6M ).
Concluding Remarks
The complex and dynamic interplay between labile and total metal pools has implications for metal homeostasis and metal dysregulation in healthy and disease states. Copper provides a prime example of this signal/stress dichotomy, as its potent redox activity makes it an essential nutrient but this same chemical reactivity makes P.14 loss of copper homeostasis a danger to the redox balance of the cell. To address the need for new chemical tools to probe labile copper pools to be used in conjunction with complementary traditional techniques for total copper status, we have developed FCP-1, a first-generation activity-based ratiometric FRET probe that enables selective imaging of labile Cu(I) pools in live cells with a self-calibrating response. FCP-1 utilizes a classic bioinorganic TPA ligand motif for Cu(I)-dependent cleavage to regulate FRET between fluorescein donor and rhodamine acceptor units in a dosedependent manner, affording high metal and oxidation state specificity for Cu(I).
Owing to its ratiometric response, FCP-1 is capable of visualizing dynamic changes in 
Materials and Methods
Full materials and procedures for the synthesis of compounds, spectroscopic characterization, cellular imaging, generation of cell lines, and cell analysis are described in SI Appendix.
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